Medical Director, ATTR‑CM Medical Strategy (US)

Pfizer, S.A. de C.V is seeking a Medical Director in the U.S. to provide scientific expertise for Transthyretin Amyloid Cardiomyopathy (ATTR‑CM) and develop U.S. medical strategies for the product Vyndamax. The role requires an MD/DO with at least 4 years of experience and skills in collaboration, strategy, and analysis. This position is hybrid, with responsibilities including supporting medical congress activities and ensuring scientific accuracy in communications, while also requiring strong analytical and interpersonal skills. #J-18808-Ljbffr